Thanks Albert, It really doesn't matter what you, me or Oncosil think or say re: CE approval. The only opinion of any current significance is that of the clinical oversight committee. And of future significance, BSI. I'm guessing we'll all be waiting for this supposed meeting. I bet my last dollar BSI have zero interest in such a meeting and will reluctantly agree to a tele/video conference. The Oncosil heavies wil delay as far as possible. And when the refusal to file letter comes, I guarantee you they will call " Brexit", "unprecedented requirements", "moved goalposts", "blah, blah, blah", as reasons for failure, and "continue to believe the clinical data meets AIMD and MedDev requirements". They have to. What else can save them from the centrelink lines and court rooms of Downing Steet? But history has been written. How much of a role has incompetence, arrogance, delusions of grandeur, and lack of ethics contributed to the outcome? Time will surely tell. Good luck to you and all those suffering from pancreatic cancer.
OSL Price at posting:
5.4¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)